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Longitudinal Measures of Lung Function in Infants
With Bronchopulmonary Dysplasia
Amy G. Filbrun,* Antonia P. Popova, Marisa J. Linn, Nancy A. McIntosh,
and Marc B. Hershenson
Summary. We previouslydemonstrated that infantswith a historyof bronchopulmonarydysplasia
(BPD) exhibit airflow obstruction and air trapping. The purpose of this study was to assess
longitudinal changes in pulmonary function in infants with a history of BPD over the first 3 years of
life, and the relationship to somatic growth. Spirometry was measured using the raised volume
rapid thoracoabdominal compression technique, and lung volumes measured by plethysmog-
raphy. Eighteen infants (mean gestational ageSD 27.32.2 weeks, birthweight 971259 g)
underwent two lung function studies. Average age at first test was 58.8 weeks. Spirometry
demonstrated significant reductions in forced expiratory volume in 0.5 sec (FEV0.5, 76.015.9%
predicted, Z-score 2.13 1.69), forced expiratory flow at 75% of expired forced vital capacity
(FEF75, 54.8 31.1%, 3.58 2.73), and FEF25–75 (67.833.3%, 1.791.76). Group mean
total lung capacity (TLC) was in the low normal range (82.913.5% predicted) and residual volume
(RV)/TLC was mildly elevated (122.4 38.2% predicted). Repeat testing was performed an
average of 32.7 weeks after initial testing. At re-evaluation, group mean lung volumes and flows
tracked at or near their previous values; thus, in general, there was a lack of catch-up growth.
However, compared to infants with below average or average somatic growth (as represented by
g/day), infants with above average growth showed significantly greater improvements in percent
predicted FVC, FEV0.5, TLC, and RV/TLC (all P<0.05, ANOVA). We conclude that longitudinal
measures of pulmonary function in infants and young children with BPD demonstrate significant
airflow obstruction and modest restriction, which tends to persist with time. On the other hand,
infantswith above average somatic growth showed greater lung growth than their peers. Additional
studies examining the effects of various nutritional regimens on lung function are warranted.
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INTRODUCTION
Bronchopulmonary dysplasia (BPD) is currently
defined as a lung disease resulting from mechanical
ventilation and oxygen therapy in infants born prema-
turely who require oxygen at 36 weeks postmenstrual
age.1 The epidemiology and natural history of BPD have
evolved in recent years. With widespread use of prenatal
steroids, exogenous surfactant, high frequency oscillatory
mechanical ventilation and other modalities, survival of
smaller, more premature infants has become a frequent
occurrence.2 Reductions in the intensity of mechanical
ventilation and oxygen supplementation, superimposed
on a more immature lung, have led to changes in the
clinical and pathologic features of BPD.3 In contrast to
the airway inflammation, fibrosis, and smooth muscle
hypertrophy observed in earlier cohorts, ‘‘new’’ BPD is
primarily a disease of an arrest of alveolarization.
Advent of the raised volume rapid thoracoabdominal
compression (RVRTC) technique has allowed a more
comprehensive description of airway function and lung
volumes in infants with a history of BPD. Normal values
for forced expiratory flow in infants using this technique
have been established.4 We have shown that infants with
BPD continue to have significant reductions in forced
expiratory flows and increased lung volumes indicative of
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hyperinflation and air trapping, and that infants with the
most severe obstruction also demonstrate increased
bronchodilator responsiveness.5 However, few studies
have examined longitudinal lung function in infants with
BPD. Tepper et al.6 found that both functional residual
capacity (FRC) and Vmax FRC, the expiratory flow rate
obtained during a partial forced expiratory maneuever,
were significantly decreased in BPD. FRC subsequently
increased to normal, but Vmax FRC remained about half
normal, perhaps indicative of poor growth of the airways.
Gerhardt et al.7 found that lung compliance and FRC were
decreased in the first 6 months of life but improved
thereafter, presumably due to catch-up growth of the lung.
Mallory et al.,8 using the forced deflation technique, found
that, in patients with moderate-to-severe BPD requiring
tracheostomy, forced vital capacity (FVC) caught up to
normal levels by 36 months of age, but that severe lower
airway obstruction, as assessed by maximum expiratory
flow at 25% FVC, persisted in all infants. Subsequent
studies of babies with ‘‘new’’ BPD also show persistently
low Vmax FRC values.
9,10 However, longitudinal measure-
ments of lung function in infants using the RVRTC
technique, which measures airway function throughout
the full range of lung volumes and is independent of
dynamically maintained FRC,11 have not been performed.
Growth failure and malnutrition are common in infants
with BPD. The precise causes of poor growth are
unknown, but likely relate to dysfunction of other organ
systems, decreased nutrient intake and increased energy
requirements. Optimizing growth has remained a princi-
pal goal of nutritional support in infants with BPD,
although the relationship between somatic growth and
lung growth is not well defined. Historically, an increased
growth rate to achieve ‘‘catch-up’’ growth has been the
goal of nutritional support. On the other hand, a recent
study of term infants found that higher rates of weight
gain in early infancy are associated with impaired lung
development.12 We therefore assessed longitudinal
changes in pulmonary function using the RVRTC
technique and the relationship between lung function
and somatic growth in infants with a history of BPD.
MATERIALS AND METHODS
Subjects
Infants with BPD who were undergoing infant lung
function testing for routine clinical assessment were
recruited to participate in this study. All subjects are
followed and were referred for testing by the physicians in
the Section of Pediatric Pulmonology at the University
of Michigan. Eighteen infants with a history of BPD
underwent at least two studies of lung function at
University of Michigan between October, 2003 and
May, 2007. Subject characteristics are shown in Table 1.
All infants were<3 years of age at the time of the baseline
study, and were at their baseline state of health, with no
signs of acute respiratory symptoms for at least 2 weeks
prior to testing. All infants were breathing room air
at the time of study. The study was approved by the
University of Michigan Institutional Review Board.
Informed consent was obtained from one parent or legal
guardian.
Lung Function Measurements
Infants were sedated with 75–100 mg/kg of chloral
hydrate given orally. Heart rate and oxygen saturation
were monitored continuously. Maximal expiratory flow
volume (MEFV) curves were obtained using the RVRTC
technique, as previously described (Collins IPL, nSpire
Health, Longmont, CO).4,13 FVC, forced expiratory
volume in 0.5 sec (FEV0.5), forced expiratory flow at
25% of expired FVC (FEF25), FEF50, FEF75, FEF85, and
FEF25–75 were measured. Analysis was based on the best
loop, defined as the maneuver with the highest sum of
FVC and FEF25–75. All curves used for analysis had FVC
measurements within 10% of the highest baseline FVC for
that set of maneuvers.
FRC was measured using a 90.5L Plexiglas whole
body plethysmograph.14 Measurements of FRC preceded
MEFV maneuvers both at baseline and following
albuterol treatment. Fractional lung volumes were calcu-
lated from FRC, FVC, and expiratory reserve volume as
described. Expiratory forced flows and fractional lung
volumes are expressed as percent of predicted for
length.4,14
Measurement of Bronchodilator Responsiveness
Infants had not received a bronchodilator for at least 6 hr
prior to testing. Albuterol was administered as described
previously.15 Briefly, albuterol was given using a metered
dose inhaler with a spacer in a dose of 2–8 puffs (180–
720mg), as needed to produce a 10% increase in heart rate.
Each puff was followed by an inflation of the lungs to
25 cmH2O. MEFV curves and lung volume measures were
repeated beginning at 10 min following the first dose of
albuterol.
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TABLE 1— Subject Characteristics
Mean SD (range), n¼ 18
Gestational age, weeks 27.3 2.2 (24.0–31.6)
Birthweight (g) 971.3 259.3 (435–1387)
Gender, M/F 8/10
Race, %Caucasian 83%
Mechanical ventilation, total days 37.2 33.5 (1–89)
Supplemental oxygen, total days 235 131.2 (42–495)
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Growth Calculation
Growth rate was calculated based on weight gain
(g/day) between studies, and subjects were compared to
expected rates.16
Statistical Analysis
Data are expressed as the mean standard deviation
(SD). Spirometric measurements of lung function are
expressed as both percent predicted and Z-score.4,14
For spirometric measurements, the loop with the highest
sum of FVC and FEF25–75 was recorded for analysis.
Plethysmographic lung volumes are expressed as percent
predicted.14
Body weights and lengths are expressed as percentile
and Z-score. Changes in pulmonary function measures
from baseline to follow-up and changes per unit length
were compared using paired t-tests. Group means for
somatic growth data were compared using one-way
analysis of variance with Bonferroni correction for
multiple comparisons where indicated. Bivariate correla-




Eighteen infants with a history of BPD underwent
two tests of pulmonary function. Babies tended to be
extremely low-birth weight (average gestational age,
27.3 weeks, range, 24.0–31.6 weeks; average birth
weight, 971 g, range, 435–1387 g). Infants required an
average of 235 days of supplemental O2 (range, 42–
495 days), indicating a diagnosis of ‘‘moderate’’ to
‘‘severe’’ BPD.1 Average age at the time of first study
was 58.8 17.6 weeks. Repeat testing was performed an
average of 32.7 weeks after initial testing.
Forced Expiratory Maneuvers
Forced expiratory maneuvers were performed using the
RVRTC technique. When adjusted for body size, FVC was
low normal at baseline and mildly reduced at follow-up
compared to a cohort of normal infants4 (Table 2). Average
FEF75, a measure of flow at low lung volumes, was
severely reduced at both baseline and follow-up. Longi-
tudinal changes in individual values of FEF75 are plotted
against length in Figure 1. On average, changes in FEF75
tracked at the predicted slope but substantially below
predicted values, indicating a lack of catch-up growth. On
a percent predicted basis, there was no difference in FVC,
FEV0.5, FEF75, or FEF25–75 between the first and second
lung function tests.
Fractional Lung Volumes
Consistent with the FVC data, average TLC was low
normal at baseline when adjusted for body size,14 and
there was no change at follow-up (Table 1). When
individual values of TLC were plotted against length,
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TABLE 2— Subject Demographics and Pulmonary Function
Baseline, mean (SD) Z-score (SD) Follow-up, mean (SD) Z-score (SD)
Age at study, weeks 58.79 (17.55) 91.44 (31.11)1
Weight, kg 8.64 (1.71) 1.34 (1.06) 10.80 (1.85)1 0.97 (1.12)
Length, cm 70.04 (6.54) 2.30 (1.46) 80.77 (6.39)1 1.36 (1.40)
FVC, % predicted 81.4 (16.6) 1.53 (1.57) 79.8 (16.2) 1.63 (1.33)
FEV0.5, % predicted 76.0 (15.9) 2.13 (1.69) 77.6 (14.6) 1.94 (1.42)
FEF75, % predicted 54.8 (31.1) 3.58 (2.73) 54.9 (28.0) 3.54 (2.76)
FEF25–75, % predicted 67.8 (33.3) 1.79 (1.76) 70.5 (28.1) 1.56 (1.63)
FRC, % predicted 98.5 (23.6) 97.3 (18.2)
TLC, % predicted 82.9 (13.5) 80.2 (10.0)
RV, % predicted 134.1 (32.4) 126.8 (31.4)
RV/TLC, % predicted 145.5 (33.7) 146.4 (35.4)
Bronchodilator responsive 6/15 4/14
P< 0.001 baseline vs. follow-up.
Fig. 1. Longitudinal measures of FEF75 versus length. On
average, changes in FEF75 per unit length track at the predicted
slope but substantially below predicted values (heavy line),
indicating a lack of catch-up growth.
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changes in TLC tracked at the predicted slope,4,14 again
indicating a lack of catch-up growth (Fig. 2). Consistent
with the severe reduction in flow rates at low-lung volumes
noted above, RV/TLC ratio was increased at baseline
and follow-up, indicative of air trapping. On a percent
predicted basis, there was no difference in FRC, TLC, RV,
or RV/TLC between tests.
We also examined whether there was a relationship
between expiratory flow, plethysmographic lung volumes,
and the severity of prematurity or neonatal lung disease.
There was no statistical correlation between any measures
of pulmonary function and birthweight, gestational age,
days of mechanical ventilation, or days of oxygen therapy.
Bronchodilator Responsiveness
At baseline, 6 out of 15 (40%) infants showed signi-
ficant bronchodilator responsiveness, as defined by a
change in FEF75 >24.3%, which is 2 standard deviations
from the mean change for previously published normal
infants who received placebo.4 At follow-up, 4 out of
14 (29%) infants showed bronchodilator responsiveness.
Growth Measurements
Infants were weighed at baseline and follow-up and
subsequently divided into two groups on the basis of
weight gain (g/day) in comparison to the expected rate.16
The pulmonary function parameters of infants growing
at below average (n¼ 3) or average (n¼ 6) rates were
compared to infants growing at above average rates
(n¼ 9). There was no difference in group mean weight,
length, or age between the two groups (not shown).
Baseline FVC was higher in infants who grew at below
average or average growth (Table 3). On the other hand,
compared to infants with below average or average
growth, infants with above average growth showed
proportionally greater improvements in FVC, FEV0.5,
TLC, and RV/TLC (all P< 0.05, ANOVA). When all
infants were considered together, somatic growth signifi-
cantly correlated with changes in percent predicted
FVC, FEV0.5, and RV/TLC (Fig. 3). On the other hand,
parameters of airflow (FEF75, FEF25–75) were not
significantly different between groups.
DISCUSSION
The precise biological mechanisms responsible for
alveolar arrest in the ‘‘new BPD’’ are unclear. Data
suggest that BPD results from a complex interplay
between inflammation and alveolar/vascular develop-
ment, with interleukin (IL)-1b,17,18 vascular endothelial
growth factor,19–21 transforming growth factor-b,22,23 and
the myofibroblast24,25 playing key roles. In the present
study, we found that infants with a history of moderate-to-
severe BPD demonstrate a severe reduction in flows at
low-lung volumes, as evidenced by reductions in FEF75.
Accordingly, babies also demonstrated air trapping, as
shown by increased RV/TLC values. Average FVC and
TLC values were in the low normal or mildly reduced
range, indicating modest restriction. Despite abnormal
airway function, bronchodilator responsiveness was
present in only a minority of infants.
Infants with a history of BPD were re-studied an
average of 32 weeks after initial testing, at a mean
postnatal age of almost 2 years. Severe reductions in flow
at low lung volumes, consistent with peripheral airways
obstruction and resultant air trapping, persisted. In
addition, FVC decreased into the mildly reduced range
compared to a cohort of normal infants.4 Average TLC
remained in the low normal range. Thus, longitudinal
measures of lung function showed little change with
growth, with abnormalities in forced expiratory flow, lung
volume, and compliance persisting over time. These data
confirm and extend previous work showing no improve-
ment in Vmax FRC with time in infants with a history of
BPD.6,9,10 However, since Vmax FRC measurements are
obtained at dynamically maintained end-expiratory vol-
ume,11 our data provide a more accurate measure of the
level of airflow obstruction. These data are consistent with
recent studies in school age children showing persistent
abnormalities in small airways function in infants with a
history of moderate-to-severe BPD, in spite of surfactant
treatment.26,27 Together, these results add new, more
accurate information on lung function in infants with a
history of BPD, at a time period in development when
previous data were lacking.
It has been argued that changes in lung function in
infants with BPD fundamentally reflect premature birth,
rather than lung injury. However, when compared to
results in healthy premature infants,28,29 infants with BPD
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Fig. 2. Longitudinal measures of TLC versus length. TLC
measures for individual subjects (black lines) track at or below
the predicted values per unit length, as determined by Castile
et al.14 (heavy line). Indeed, the majority of our data points fell
below Castile’s lower 95% confidence limit, consistent with the
notion that TLC was significantly reduced in infants with BPD.
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showed further diminished levels of airflow, suggesting
that lung function changes in BPD cannot be fully
explained by prematurity alone.
The prevalence of bronchodilator responsiveness in
infants with a history of BPD was <30% at follow-up. In
our previous study, 35% of infants with a history of BPD
were bronchodilator responsive,5 and only half of the
infants with a history of recurrent wheezing demonstrated
a significant change in airflow with bronchodilator
administration. Together, these results suggest that airflow
obstruction in these infants is not fully explained by
airway smooth muscle dysfunction, and that an alternative
mechanism is possible. Consistent with this, preschool
children with a history of BPD do not show bronchial
responsiveness to adenosine 5-monophosphate,30 indicat-
ing the lack of an airway inflammatory response
characteristic of asthmatic subjects. One potential mech-
anism for airway narrowing is hypoalveolarization, which
would reduce the number of alveolar attachments per
airway, leading to reduced airway–parenchymal cou-
pling. Airway–parenchymal coupling in BPD may also be
reduced by thickening of the outer airway wall.31 Airway
narrowing could also relate to smaller-sized airways,
decreased pulmonary elastic recoil, more collapsible
airways, and increased bronchial tone. Finally, it is
conceivable that airway edema, fibrosis, and airway
smooth muscle hypertrophy, structural changes in the
‘‘old BPD,’’ continue to play a role.
Consistent with animal studies demonstrating the
deleterious effects of malnutrition on lung development,32
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TABLE 3— Comparison of Lung Function Changes in Infants With Below Average or
Average Somatic Growth (n¼ 9) to Infants With Above Average Somatic Growth (n¼ 9)
Growth parameter
Somatic growth
Below average or average Above average P-value1
Somatic growth grams/day, mean (SD) 4.8 (2.1) 10.0 (2.2) <0.001
Weight for age, Z-score, mean (SD)
First test 1.46 (1.18) 1.23 (0.98) 0.659
Second test 1.59 (1.18) 0.35 (0.65) 0.013
Change 0.14 (0.42) 0.88 (0.90) 0.007
Height for age, Z-score, mean (SD)
First test 2.51 (1.43) 2.10 (1.55) 0.561
Second test 1.92 (1.31) 0.81 (1.33) 0.093
Change 0.60 (0.70) 1.29 (1.42) 0.208
FVC, Z-score, mean (SD)
First test 0.67 (0.41) 2.40 (1.83) 0.014
Second test 1.36 (0.77) 1.90 (1.72) 0.405
Change 0.69 (0.65) 0.50 (1.29) 0.025
FEV0.5, Z-score, mean (SD)
First test 1.54 (0.99) 2.72 (2.07) 0.142
Second test 1.90 (1.31) 1.99 (1.61) 0.900
Change 0.36 (0.54) 0.73 (1.12) 0.018
FEF75, Z-score, mean (SD)
First test 3.92 (2.30) 3.24 (3.21) 0.613
Second test 3.87 (2.80) 3.21 (2.86) 0.627
Change 0.05 (1.06) 0.03 (0.9) 0.969
FEF25–75, Z-score, mean (SD)
First test 2.03 (1.50) 1.55 (2.04) 0.579
Second test 1.86 (1.69) 1.25 (1.60) 0.446
Change 0.17 (0.55) 0.30 (0.69) 0.669
TLC, % predicted, mean (SD)
First test 87.7 (8.3) 78.2 (16.4) 0.143
Second test 82.1 (9.1) 78.3 (11.1) 0.441
Change 7.5% (7.1%) 1.7% (10.4%) 0.044
RV, % predicted, mean (SD)
First test 101.4 (23.8) 108.6 (44.3) 0.677
Second test 105.3 (28.3) 103.6 (33.0) 0.904




First test 109.8 (16.9) 135.1 (49.6) 0.166
Second test 123.8 (25.8) 131.8 (45.4) 0.652
Change 7.8% (9.7%) 2.8% (10.1%) 0.037
1P-value calculated by ANOVA.
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we demonstrated higher longitudinal changes in pulmo-
nary function (specifically FVC, FEV0.5, TLC, and RV/
TLC) in infants with above average somatic growth. On
the other hand, measurements of airflow such as FEF75 and
FEF25–75 were not different between groups. These data
suggest an association between improved nutrition and
lung (but perhaps not airway) growth. Few reports have
examined the effect of nutrition on pulmonary function in
infants with a history of BPD. A previous study showed a
significant correlation between undernutrition at 2 years of
age and lung hyperinflation, as defined by a helium
dilution FRC of>120% predicted, at 4–8 years of age.33 It
should be noted that specific nutrients such as vitamins,
amino acids, trace elements, inositol, and glutathione also
play an important role in lung development and repair, in
addition to caloric intake.34 Also, measurement of body
weight does not distinguish between the accumulation of
fat or muscle, a determination which could be made by
measurements of body composition.
There are a number of limitations to our study. There is a
paucity of normative, control data with which to compare
our results, especially the lung volume measurements.
Because the RVRTC technique requires sedation, it is
particularly difficult to obtain lung function data from
normal infants. We were therefore forced to compare our
longitudinal results with cross-sectional reference data.
Also, on average, our first measurements were made at
approximately 1 year of age, making it difficult to
comment on the relationship between growth and lung
function in the first year of life, when lung development
and somatic growth are most rapid. However, since our
two longitudinal measurements showed remarkably con-
sistent reductions in airflow and lung volume, it is unlikely
that earlier measurements would have revealed a different
pattern. Finally, the observed correlation between weight
gain and selected parameters of pulmonary function does
not establish a cause and effect relationship between
somatic growth and lung growth.
We conclude that, based on longitudinal measurements
of pulmonary function using the RVRTC technique,
infants with a history of moderate-to-severe BPD show
persistent, severe reductions in airflow at low lung
volumes. Such reductions may be due to persistent smooth
muscle dysfunction and/or hypertrophy, airway fibrosis,
impaired airway growth, or hypoalveolarization. On the
other hand, infants with above average somatic growth
showed greater lung growth than their peers. Controlled
randomized studies examining the effects of various
nutritional regimens on lung function are warranted.
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